ArticleJournal of cancer research and clinical oncology2022

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

Sang-A Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.